Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer
Journal of Clinical Oncology
JCO Early Release, published online ahead of print Oct 13 2004
John Rinehart, Alex A. Adjei, Patricia M. LoRusso, David Waterhouse, J. Randolph Hecht, Ronald B. Natale, Oday Hamid, Mary Varterasian, Peggy Asbury, Eric P. Kaldjian, Stephen Gulyas, David Y. Mitchell, Roman Herrera, Judith S. Sebolt-Leopold, and Mark B. Meyer
DOI: 10.1200/JCO.2004.01.185
Go to journal article.
Journal Article: Oral CI-1040 and Advanced Colon CancerCancer Research - October 2004
From Donna Myers, former About.com Guide
About.com Health's Disease and Condition content is reviewed by the Medical Review Board
Explore Colon Cancer
Must Reads
About.com Special Features
8 Ways to Cut Drug Costs
Learn how to save money on medications with these recommendations. More >
Healthy Bodies, Healthy Minds
Keep yourself, and your family, happy and healthy this fall with these tips. More >
Also from About.com:
©2009 About.com, a part of The New York Times Company.
All rights reserved.